Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of 11 added items of the outpatient version of the Utrecht Symptom Diary in patients receiving chemotherapy or targeted therapy.
Koldenhof JJ, Akpobome BO, Zweers D, Klaasse S, Teunissen SCCM, Witteveen PO, Suijkerbuijk KPM, de Graeff A, van der Baan FH. Koldenhof JJ, et al. Among authors: van der baan fh. J Patient Rep Outcomes. 2024 Oct 18;8(1):120. doi: 10.1186/s41687-024-00794-w. J Patient Rep Outcomes. 2024. PMID: 39422800 Free PMC article.
Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancer.
van de Weerd S, Torang A, van den Berg I, Lammers V, van den Bergh S, Brouwer N, Nagtegaal ID, Koopman M, Vink GR, van der Baan FH, van Krieken H, Koster J, Ijzermans JN, Roodhart JML, Medema JP. van de Weerd S, et al. Among authors: van der baan fh. Int J Cancer. 2025 Jan 15;156(2):456-466. doi: 10.1002/ijc.35120. Epub 2024 Aug 8. Int J Cancer. 2025. PMID: 39115332 Free PMC article.
Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort.
Zwart K, van der Baan FH, Punt CJA, Wensink GE, Bolhuis K, Laclé MM, van Grevenstein WMU, Hagendoorn J, de Hingh IH, Koopman M, Vink G, Roodhart J. Zwart K, et al. Among authors: van der baan fh. Ann Surg Oncol. 2023 Oct;30(11):6762-6770. doi: 10.1245/s10434-023-13974-7. Epub 2023 Aug 1. Ann Surg Oncol. 2023. PMID: 37528303 Free PMC article.
Prognostic value of Lynch syndrome, BRAFV600E , and RAS mutational status in dMMR/MSI-H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts.
Zwart K, van der Baan FH, Cohen R, Aparicio T, de la Fouchardiére C, Lecomte T, Punt CJA, Sefrioui D, Verheijden RJ, Vink GR, Wensink GE, Zaanan A, Koopman M, Tougeron D, Roodhart JML. Zwart K, et al. Among authors: van der baan fh. Cancer Med. 2023 Aug;12(15):15841-15853. doi: 10.1002/cam4.6223. Epub 2023 Jun 16. Cancer Med. 2023. PMID: 37326121 Free PMC article.
Patient-Reported Outcomes During Checkpoint Inhibition: Insight into Symptom Burden in Daily Clinical Practice.
Koldenhof JJ, van der Baan FH, Verberne EG, Kamphuis AM, Verheijden RJ, Tonk EH, van Lindert AS, van der Stap J, Teunissen SC, Witteveen PO, Suijkerbuijk KP. Koldenhof JJ, et al. Among authors: van der baan fh. J Pain Symptom Manage. 2022 Jun;63(6):997-1005. doi: 10.1016/j.jpainsymman.2022.02.013. Epub 2022 Feb 20. J Pain Symptom Manage. 2022. PMID: 35196557 Free article.
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Lakeman IMM, van den Broek AJ, Vos JAM, Barnes DR, Adlard J, Andrulis IL, Arason A, Arnold N, Arun BK, Balmaña J, Barrowdale D, Benitez J, Borg A, Caldés T, Caligo MA, Chung WK, Claes KBM; GEMO Study Collaborators; EMBRACE Collaborators; Collée JM, Couch FJ, Daly MB, Dennis J, Dhawan M, Domchek SM, Eeles R, Engel C, Evans DG, Feliubadaló L, Foretova L, Friedman E, Frost D, Ganz PA, Garber J, Gayther SA, Gerdes AM, Godwin AK, Goldgar DE, Hahnen E, Hake CR, Hamann U, Hogervorst FBL, Hooning MJ, Hopper JL, Hulick PJ, Imyanitov EN; OCGN Investigators; HEBON Investigators; KconFab Investigators; Isaacs C, Izatt L, Jakubowska A, James PA, Janavicius R, Jensen UB, Jiao Y, John EM, Joseph V, Karlan BY, Kets CM, Konstantopoulou I, Kwong A, Legrand C, Leslie G, Lesueur F, Loud JT, Lubiński J, Manoukian S, McGuffog L, Miller A, Gomes DM, Montagna M, Mouret-Fourme E, Nathanson KL, Neuhausen SL, Nevanlinna H, Yie JNY, Olah E, Olopade OI, Park SK, Parsons MT, Peterlongo P, Piedmonte M, Radice P, Rantala J, Rennert G, Risch HA, Schmutzler RK, Sharma P, Simard J, Singer CF, Stadler Z, Stoppa-Lyonnet D, Sutter C, Tan YY, Teixeira MR, Teo SH, Teulé A, Thomassen M, Thull DL, Tischkowitz M, Toland AE… See abstract for full author list ➔ Lakeman IMM, et al. Genet Med. 2021 Sep;23(9):1726-1737. doi: 10.1038/s41436-021-01198-7. Epub 2021 Jun 10. Genet Med. 2021. PMID: 34113011 Free PMC article.
23 results